1Jian-Dang Zhou, Jian-Jun Guo, Qin Zhang, Yin Chen, Shai-Hong Zhu and Huai-Yan Peng Department of Clinical Laboratory Institute of Organ Transplantation the Third Xiangya Hospital of Central South University,Department of Medical Laboratories College of Medical Technology and Information of Central South University, Changsha 410013, China.Drug resistance of infectious pathogens after liver transplantation[J].Hepatobiliary & Pancreatic Diseases International,2006,5(2):190-194. 被引量：3
4[1]Johnson MA, Horak J, Breuel P. The pharmacokinetics of lamivudine in patients with impaired hepatic function[J]. Eur J Clin Pharmacol, 1998, 54(4): 363-366.
5[3]Yamamura Y, Tanaka N. The relationship between pharmacokinetic behaviour of glycyrrhizin and hepatitis and liver cirrhosis[J]. Biopharm Drug Dispos, 1995, 16(1): 13-21.
6黄颖秋，国外医学.消化系统疾仓册，1997年，17卷，79页
7黄自平，肝脏病学，1995年，397页
8Lee J I，Trans plant Proc，1996年，28卷，2156页
9VIMAL V,DEVAKI T. Hepatoprotective Effect of Allicin on Tissue Defense System in Galactosamine/Endotoxin Challenged Rats [J ]. J Ethnopharmacol (S0378 -6411), 2004,90(1) :151-154.
10YAROVINSKY TO, POWERS LS,BUTLER NS,et al.Adenoviral Infection Decreases Mortality from Lipopolysaccharide-induced Liver Failure Via Induction of TNF-alpha Tolerance[J]. J Immunol(S0022-1767) ,2003,171(5) :2453-2460.
